Prescribing topical steroids to manage flares

To manage eczema flares, your patients may need more than emollient therapy alone and guidelines recommend the use of topical steroids1,4, which come as creams and ointments, in a range of strengths (mild, moderate, potent and very potent).

Product7,8 Severity of eczema
Brand Generic Potency Mild Moderate Severe
Dioderm Hydrocortisone 0.1% Mild
Mildison Lipocream Hydrocortisone 0.1% Mild
Synalar 1 in 10 Fluocinolone acetonide 0.0025% Mild
Betnovate RD Betamethasone valerate 0.025% Moderate
Eumovate Clobetasone butyrate 0.05% Moderate
Haelan Fludroxycortide 0.0125% Moderate
Modrasone Alclometasone dipropionate 0.05% Moderate
Synalar 1 in 4 Fluocinolone acetonide 0.00625% Moderate
Ultralanum Fluocortolone 0.25% Moderate
Betnovate Betamethasone valerate 0.1% Potent
Cutivate Fluticasone propionate 0.05% Potent
Diprosone Betamethasone dipropionate 0.05% Potent
Elocon Mometasone furoate 0.1% Potent
Locoid Hydrocortisone butyrate 0.1% Potent
Metosyn Fluocinonide 0.05% Potent
Nerisone Diflucortolone valerate 0.1% Potent
Synalar Fluocinolone acetonide 0.025% Potent
Dermovate Clobetasol propionate 0.0525% Very potent Adults only

A full list of topical steroids can be found on the British National Formulary (BNF) website7

When prescribing a topical steroid, it is preferable to choose one with a once-daily application to improve adherence. A step-wise approach should be used – starting with the correct potency based on the severity of the eczema, then 9:

The location of the eczema should also be considered in the prescribing decision; for example, treatment of eczema on delicate areas of skin, such as the face, should only be with a mild steroid.1


References:
  1. 1.NICE (2007) Atopic eczema in children. Management of atopic eczema in children from birth up to the age of 12 years. Clinical Guideline 57, London, December 2007
  2. 4.Primary Care Dermatology Society & British Association of Dermatologists (2009) Guidelines for the management of atopic eczema. (PCDSBAD-Eczema.pdf Accessed December 2011)
  3. 7.BNF 62. September 2011. www.bnf.org.uk
  4. 8.MIMS online. www.mims.co.uk/Drugs/skin/inflammatory-skin-conditions/
  5. 9.NICE (2004) Frequency of application of topical steroids for atopic eczema. Technology Appraisal 81, August 2004

Code: 12/13 DERM-1018018-0001
Date of preparation: December 2011